Lv1
40 积分 2024-05-23 加入
Health‐related quality‐of‐life and treatment targets in myasthenia gravis
1小时前
待确认
Evaluating inebilizumab in the treatment of generalized myasthenia gravis
4天前
已完结
Complement inhibitors for myasthenia gravis in adults
5天前
已完结
Local complement inhibition by selective precision-targeted therapies
6天前
已关闭
Complement deficiencies and infections
6天前
已关闭
Advances in understanding ferroptosis mechanisms and their impact on immune cell regulation and tumour immunotherapy
9天前
已关闭
Humoral correlates of clinical response to thymectomy in myasthenia gravis
10天前
已关闭
AAV-mediated DMPK silencing: A defining moment in myotonic dystrophy type 1 therapeutics
12天前
已关闭
New insights into the management of fulminant myocarditis
20天前
已关闭
Immune dysfunction in Alzheimer disease
21天前
已完结
皖公网安备34019202002308
